Topical Antifungal Treatment for Tinea Cruris

NCT01342315 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

483

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Cruris

Interventions

DRUG: 33525
DRUG: Placebo

Sponsor

Medicis Global Service Corporation